PRA’s state-of-the-art Early Development Services (EDS) facilities allow us to undertake over 100 clinical studies and more than 200 bioanalytical studies each year. Our database of more than 30,000 patients and volunteers based in Europe and the United States give PRA an unrivalled advantage accounting for our phenomenal success.
With clinical centers and bioanalytical laboratories across Europe and the US and a network of external sites (India, South Korea, China, Australia and New Zealand), PRA is able to maximize our expertise and host early phase trials in an effective and efficient manner.
Clinical Pharmacology Centers
Groningen & Zuidlaren, The Netherlands
- Two 70-bed Clinical Pharmacology Units
- Local PRA bioanalytical laboratory for rapid sample processing
- GLP-compliant clinical laboratory
- First-in-Man through Proof-of-Concept studies
- GMP-licensed in-house pharmacy for manufacture, preparation support, study batch dispensing and labeling (Annex 13)
- Groningen is university hospital-based with direct access to an Intensive Care Unit, neuro-imaging and PET Center
- Collaboration with the University Medical Center Groningen (UMCG), focusing on neuro-imaging (e.g. PET, (f)MRI, EEG, cognitive testing) and pain modeling
- Expertise in CNS (including pain), infectious and metabolic diseases and HCV
- Netherland’s ethics board full regulatory approval within 2 weeks
Click here to tour our clinic in the Netherlands 
Lenexa
- State-of-the-art 100-bed Clinical Research Unit
- Focused on First-in-Man through Proof-of-Concept
- Vaccine studies GCP-practicing pharmacy with temperature and humidity control
- Local PRA bioanalytical laboratory for rapid sample processing
- Coming soon: licensure for ADME and Microdosing (Phase 0) study
Click here to tour our clinic in Lenexa
